DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /Aromatic HeterocyclesAromatic Heterocycles
  6. /BrinzolamideBrinzolamide
Chemical structure of CAS 138890-62-7

Brinzolamide

In Stock•Starting at $29 for 100 mg•Purity ≥ 97%
CAS No.138890-62-7
MDL No.MFCD08067749
MFC12H21N3O5S3
MW383.50
InChI KeyHCRKCZRJWPKOAR-JTQLQIEISA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
100 mg97%$29In Stock
250 mg97%$48In Stock
500 mg97%$76In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Brinzolamide is a sulfonamide and thienothiazine, functioning as an antiglaucoma drug and inhibitor of carbonic anhydrase (EC 4.2.1.1).

CAS No.138890-62-7
Product NameBrinzolamide

Biological Targets

CA2

Associated Conditions

open-angle glaucoma·central serous retinopathy·glaucoma·ocular hypertension
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Advances in topical glaucoma therapy.

Veterinary ophthalmology • Vol. 5, Issue 1 • 2002
PMID: 11940242DOI: 10.1046/j.1463-5216.2001.00202.x

Brinzolamide.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • Vol. 58, Issue 22 • 2001
PMID: 11760914DOI: 10.1093/ajhp/58.22.2139

[Innovative glaucoma therapy. Glaucoma therapy with topical carbonic anhydrase inhibitors].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft • Vol. 98, Issue 10 • 2001
PMID: 11699313DOI: 10.1007/s003470170039

Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

American journal of ophthalmology • Vol. 132, Issue 2 • 2001
PMID: 11476685DOI: 10.1016/s0002-9394(01)00974-6

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact